SCHEMBL4100696

SCHEMBL4100696

CP(C)(=O)CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.71
NPSR1 Q6W5P4 3/20 0.43
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 5/20 0.42
ATM Q13315 3/20 0.42
TDP1 Q9NUW8 3/20 0.41
GAA P10253 2/20 0.41
POLB P06746 1/20 0.41
KIT P10721 7/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
EGFR P00533 1/20 0.39
BRAF P15056 1/20 0.39
RECQL P46063 1/20 0.39
RET P07949 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1279087 0.83 NR1H2 (0.79) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL29493475 0.83 NR1H2 (1.00) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL273351 0.83 NR1H2 (1.00) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL4105203 0.82 NR1H2 (0.48) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL545052 0.82 NR1H2 (0.76) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL4933173 0.82 NR1H2 (0.76) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL4937761 0.81 NR1H2 (0.75) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL15688199 0.81 NR1H2 (0.80) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL4931424 0.81 NR1H2 (0.75) NR1H2NPSR1KDM4EALDH1A1ATM
SCHEMBL15598307 0.81 NR1H2 (0.74) NR1H2NPSR1KDM4EALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090561-B2 Acetylenic heteroaryl compounds ARIAD PHARMACEUTICALS, INC. (US) 2015-07-28 US disclosed
US-8461167-B2 Acetylenic heteroaryl compounds ARIAD PHARMACEUTICALS, INC. (US) 2013-06-11 US disclosed
US-20130018046-A1 Acetylenic Heteroaryl Compounds ARIAD PHARMACEUTICALS, INC. (US) 2013-01-17 US disclosed
US-20090176781-A1 Acetylenic Heteroaryl Compounds ARIAD PHARMACEUTICALS, INC. 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176781-A1 Acetylenic Heteroaryl Compounds NAT1, AADAC, ACACA NR1H2 552/4885NPSR1 1366/4885KDM4E 3538/4885
US-20130018046-A1 Acetylenic Heteroaryl Compounds NAT1, AADAC, ACACA NR1H2 552/4885NPSR1 1366/4885KDM4E 3538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.